Nasus Pharma Ltd (NSRX) › Capital ExpendituresNasus Pharma Ltd (NSRX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.Fiscal YearCapital ExpendituresChange YoY2025$14.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share